These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27149919)

  • 1. Diagnostic delay in narcolepsy type 1: combining the patients' and the doctors' perspectives.
    Taddei RN; Werth E; Poryazova R; Baumann CR; Valko PO
    J Sleep Res; 2016 Dec; 25(6):709-715. PubMed ID: 27149919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study.
    Luca G; Haba-Rubio J; Dauvilliers Y; Lammers GJ; Overeem S; Donjacour CE; Mayer G; Javidi S; Iranzo A; Santamaria J; Peraita-Adrados R; Hor H; Kutalik Z; Plazzi G; Poli F; Pizza F; Arnulf I; Lecendreux M; Bassetti C; Mathis J; Heinzer R; Jennum P; Knudsen S; Geisler P; Wierzbicka A; Feketeova E; Pfister C; Khatami R; Baumann C; Tafti M;
    J Sleep Res; 2013 Oct; 22(5):482-95. PubMed ID: 23496005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?
    Drakatos P; Leschziner G
    J Clin Sleep Med; 2016 Mar; 12(3):449-50. PubMed ID: 26564387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleepiness in Narcolepsy.
    Zhang J; Han F
    Sleep Med Clin; 2017 Sep; 12(3):323-330. PubMed ID: 28778231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1.
    van der Hoeven AE; Fronczek R; Schinkelshoek MS; Roelandse FWC; Bakker JA; Overeem S; Bijlenga D; Lammers GJ
    Sleep; 2022 May; 45(5):. PubMed ID: 35554594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Narcolepsy: etiology, clinical features, diagnosis and treatment].
    Zawilska JB; Woldan-Tambor A; Płocka A; Kużajska K; Wojcieszak J
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():771-86. PubMed ID: 23175331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
    Dauvilliers Y; Lopez R
    Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
    Kubota H; Kanbayashi T; Tanabe Y; Ito M; Takanashi J; Kohno Y; Shimizu T
    Sleep; 2003 Aug; 26(5):555-7. PubMed ID: 12938807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcolepsy with Cataplexy in an Elderly Woman.
    Suzuki S; Uehara T; Ohira Y; Ikusaka M
    J Gen Intern Med; 2015 Aug; 30(8):1222-4. PubMed ID: 25784528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
    Sturzenegger C; Bassetti CL
    J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of narcolepsy after 40.
    Rye DB; Dihenia B; Weissman JD; Epstein CM; Bliwise DL
    Neurology; 1998 Feb; 50(2):459-65. PubMed ID: 9484372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.
    Baumann CR; Mignot E; Lammers GJ; Overeem S; Arnulf I; Rye D; Dauvilliers Y; Honda M; Owens JA; Plazzi G; Scammell TE
    Sleep; 2014 Jun; 37(6):1035-42. PubMed ID: 24882898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy.
    Lopez R; Barateau L; Evangelista E; Chenini S; Robert P; Jaussent I; Dauvilliers Y
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narcolepsy with intermediate cerebrospinal level of hypocretin-1.
    Postiglione E; Barateau L; Pizza F; Lopez R; Antelmi E; Rassu AL; Vandi S; Chenini S; Mignot E; Dauvilliers Y; Plazzi G
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34902030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy.
    Maski K; Steinhart E; Williams D; Scammell T; Flygare J; McCleary K; Gow M
    J Clin Sleep Med; 2017 Mar; 13(3):419-425. PubMed ID: 27923434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.